GlassScriptPhysician profile
Marc Anthony Gorvet
NPI 1124557830
$4,458.06
in general payments reported to CMS, 2019-2025
9 companies · $2,389 in 2025
The $2,389 reported for 2025 was more than what 87% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $111 · 2022: $373 · 2023: $949 · 2024: $636 · 2025: $2,389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,067 · Travel and Lodging: $1,907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,067.30 |
| Travel and Lodging | $1,906.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $2,377.07 | 2023-2025 | Recell, Cohealyx, Permeaderm |
| Access Pro Medical, LLC | $618.57 | 2022-2025 | Matriderm, Matriderm |
| Kerecis Limited | $410.82 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Smith+Nephew, INC. | $397.59 | 2023-2025 | Grafix Pl, Stravix Mesh, Stravix Pl |
| Axogen | $307.44 | 2024-2025 | Axoguard Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Davol INC. | $140.00 | 2022 | |
| Boston Scientific Corporation | $110.61 | 2021 | |
| Poriferous LLC | $65.22 | 2023 | Su-Por Surgical Implants |
| Integra Lifesciences Corporation | $30.74 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Gorvet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.